4//SEC Filing
CytomX Therapeutics, Inc. 4
Accession 0001140361-17-026278
$CTMXCIK 0001501989operating
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 4:57 PM ET
Size
7.0 KB
Accession
0001140361-17-026278
Insider Transaction Report
Form 4
GLUCK FREDERICK W
Director
Transactions
- Sale
Common Stock
2017-06-26$14.61/sh−5,000$73,050→ 326,643 total(indirect: By Trust)
Holdings
- 3,200(indirect: By Spouse)
Common Stock
- 22,111(indirect: By LLC)
Common Stock
Footnotes (4)
- [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.38 to $14.84, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]The Reporting Person is a trustee of Frederick W. Gluck 1997 Family Trust dtd July 28, 1997.
- [F4]Richlin Partners, LLC is an entity owned of record by the spouse of the Reporting Person.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001501989
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 4:57 PM ET
- Size
- 7.0 KB